(8-bromo-11-hydroxy-9-oxo-2,3,9,10-tetrahydro-2,5-methanopyrimido[1,2-c][1,3,5]oxadiazepin-3-yl)methyl benzoate (56615-06-6)

Identification
Name:	(8-bromo-11-hydroxy-9-oxo-2,3,9,10-tetrahydro-2,5-methanopyrimido[1,2-c][1,3,5]oxadiazepin-3-yl)methyl benzoate
Synonyms:	NSC299219;NSC-299219;56615-06-6
CAS:	56615-06-6
Molecular Formula:	C₁₆H₁₄BrN₃O₅
Molecular Weight:	408.2035
InChI:	InChI=1/C16H14BrN3O5/c17-9-6-20-14-12(21)11(18-16(20)19-13(9)22)10(25-14)7-24-15(23)8-4-2-1-3-5-8/h1-6,10-12,14,21H,7H2,(H,18,19,22)
Molecular Structure:
Properties
Density:	1.91g/cm³
Refractive index:	1.772
Safety Data

Other Product

(11-hydroxy-9-oxo-2,3,9,10-tetrahydro-2,5-methanopyrimido[1,2-c][1,3,5]oxadiazepin-3-yl)methyl benzoate
11-hydroxy-3-(hydroxymethyl)-2,10-dihydro-2,5-methanopyrimido[1,2-c][1,3,5]oxadiazepin-9(3H)-one
Propanoic acid, 2-methyl-,8-[3-(4-chlorophenyl)-5-methyl-1H-pyrazol-1-yl]-1,2,4,5-tetrahydro-7-oxo-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl ester
Propanoic acid, 2,2-dimethyl-,8-[3-(4-chlorophenyl)-5-methyl-1H-pyrazol-1-yl]-1,2,4,5-tetrahydro-7-oxo-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl ester
Carbonic acid,8-[3-(4-chlorophenyl)-5-methyl-1H-pyrazol-1-yl]-1,2,4,5-tetrahydro-7-oxo-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl ethyl ester
1H-Pyrrolo[2,1-c][1,4]benzodiazepine-11-sulfinicacid,2-(3-amino-3-oxo-1-propenyl)-5,10,11,11a-tetrahydro-9-hydroxy-8-methyl-5-oxo-,monosodium salt (9CI)
2-Propenamide,3-(11-ethoxy-5,10,11,11a-tetrahydro-9-hydroxy-8-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-2-yl)-N-methyl-(9CI)
2-Propenamide,3-(5,10,11,11a-tetrahydro-9-hydroxy-11-methoxy-8-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-2-yl)-
(2E)-3-[(11R,11aS)-9-hydroxy-11-methoxy-8-methyl-5-oxo-5,10,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-2-yl]prop-2-enenitrile
(2E)-3-(9-hydroxy-11-methoxy-8-methyl-5-oxo-5,10,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-2-yl)prop-2-enamide
(+)-N-Methyl-3-(5,10,11,11a-tetrahydro-9-hydroxy-11-methoxy-8-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepine-2-yl)propenamide
7H-Pyrazolo[1,2-d][1,4,5]oxadiazepin-7-one,8-[2-(4-chlorophenyl)-5-methyl-4-thiazolyl]-1,2,4,5-tetrahydro-9-hydroxy-
1/C12H9NO/c14-9-11-3-1-2-4-12(11)10-5-7-13-8-6-10/h1-9
Carbonic acid,8-[2-(4-chlorophenyl)-5-methyl-4-thiazolyl]-1,2,4,5-tetrahydro-7-oxo-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl ethyl ester
1/C10H17NO/c12-10-7-4-8-11(10)9-5-2-1-3-6-9/h9H,1-8H
1/C11H7ClO2/c12-9-3-1-2-8(6-9)11-5-4-10(7-13)14-11/h1-7
Formamide,N-(2,4-diamino-1,4,5,6-tetrahydro-6-oxo-5-pyrimidinyl)-N-(1,2,3,6a,8,9,9a,11-octahydro-9-hydroxy-4-methoxy-1,11-dioxocyclopenta[c]furo[3',2':4,5]furo[2,3-h][1]benzopyran-8-yl)-
1/C10H8N2/c1-2-6-12-10(3-1)9-4-7-11-8-5-9/h1-8
Acetamide,N-[3-[2-(3-azabicyclo[3.2.2]non-3-yl)ethyl]-1,3,4,5-tetrahydro-8-methyl-5-oxo-2H-[1]benzopyrano[3,4-c]pyridin-9-yl]-
Benzamide,N-[3-[2-(3-azabicyclo[3.2.2]non-3-yl)ethyl]-1,3,4,5-tetrahydro-8-methyl-5-oxo-2H-[1]benzopyrano[3,4-c]pyridin-9-yl]-